Press releases
- Press releases
- Browse
Press releases
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
London UK, 11 April 2012 - Based on its recent analysis of the responsive polymer for bio-medical application market, Frost & Sullivan recognises CIS Pharma with the 2011 European Frost & Sullivan Technology Innovation Award for its unique Cellophil™ bio- More
APR and the leading pharmaceutical company in Turkey Abdi Ibrahim have entered into an exclusive license agreement for the promotion, distribution and marketing of Ondansetron Rapidfilm® in Turkey; terms of the deal were not disclosed. More
Life Science Leadership Series – Oncology
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
Hamburg, December 10th, 2010
Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development company in Buenos Aires, Argentina.
Amarin h More
Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development company in Buenos Aires, Argentina.
Amarin h More
Butyrylcholinesterase-targeted radiopharmaceuticals developed at the University of Nebraska Medical Center show promise for treatment of cancer. More
The International Contract Service Event (“ICSE”), taking place in Madrid from 9th until 11th October 2012, is co-located with the “CPhI Worldwide” – the biggest international fair for the pharmaceutical industry. More
Chronic obstructive pulmonary disease (COPD), a respiratory disease commonly known as chronic bronchitis or emphysema, is the fourth leading cause of death worldwide, but a University of Western Ontario researcher is providing new insight into the disease More
APR Applied Pharma Research s.a. opens US office in Charlotte, North Carolina More
The UK research community will soon have access to world-class medical imaging facilities in London with the signing of an agreement today between an alliance of leading London-based universities, the Medical Research Council (MRC) and the pharmaceutical More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 19 pages - $99
Nov 2010 - 26 pages - $125
Nov 2009 - $15,200
Nov 2010 - 40 pages - $500
Mar 2011 - 33 pages - $125
Jun 2011 - 34 pages - $125
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Your selection
- Therapeutic target
- Oncology del
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Anti-oxidant
- Bladder cancer
- Bone cancer
- Brain cancer
- Breast cancer
- Cancer (other)
- Cancer side effects
- Cervical cancer
- Colorectal cancer
- Head and neck cancer
- Kaposi's sarcoma
- Kidney cancer
- Leukemia
- Liver cancer
- Lung cancer
- Lymphoma
- Ovarian cancer
- Pancreatic cancer
- Polyps
- Prostate cancer
- Skin cancer
- Stomach/Esophageal
- Testicular cancer
- Transplant
- Treatments
- Tumor (other)
- Vaginal Cancer
- Womb cancer
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us